These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 737098)
21. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [TBL] [Abstract][Full Text] [Related]
22. [Comparative study of acute and chronic effects of nifedipine in patients with secondary pulmonary hypertension]. Dubiel JP; Nikodemowicz M; Zmudka K; Mazurek S; Królikowski T Kardiol Pol; 1991; 34(5):279-86. PubMed ID: 1921110 [TBL] [Abstract][Full Text] [Related]
23. Use of prostaglandin E1 to treat peri-anaesthetic pulmonary hypertension associated with mitral valve disease. Mikawa K; Maekawa N; Goto R; Yaku H; Nishina K; Obara H J Int Med Res; 1993; 21(3):161-4. PubMed ID: 8299860 [TBL] [Abstract][Full Text] [Related]
24. Effect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study. Haworth SG; Sauer U; Bühlmeyer K Br Heart J; 1980 Mar; 43(3):306-14. PubMed ID: 7437177 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974 [TBL] [Abstract][Full Text] [Related]
26. An excellent result of surgical treatment in patients with severe pulmonary arterial hypertension following mitral valve disease. Song X; Zhang C; Chen X; Chen Y; Shi Q; Niu Y; Xiao J; Mu X J Cardiothorac Surg; 2015 May; 10():70. PubMed ID: 25962897 [TBL] [Abstract][Full Text] [Related]
27. Effects of prostaglandins of the E-series on pulmonary and systemic circulations of newborn goats during normoxia and hypoxia. Tyler T; Leffler C; Wallis R; Cassin S Prostaglandins; 1975 Dec; 10(6):963-70. PubMed ID: 1208888 [TBL] [Abstract][Full Text] [Related]
28. Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery. Ward C; Hancock BW Br Heart J; 1975 Jan; 37(1):74-8. PubMed ID: 1111561 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary vasodilatory properties of prostaglandin E1 are blunted after experimental single lung transplantation. Kukkonen S; Heikkilä L; Verkkala K; Mattila S; Toivonen H J Heart Lung Transplant; 1995; 14(2):280-8. PubMed ID: 7779847 [TBL] [Abstract][Full Text] [Related]
30. Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation. Stone JG; Hoar PF; Faltas AN; Johnson LL; Edie RN; Bowman FO; Malm JR J Thorac Cardiovasc Surg; 1979 Jul; 78(1):103-9. PubMed ID: 449373 [TBL] [Abstract][Full Text] [Related]
31. EFFECTS OF PULMONARY VASCULAR CONGESTION ON POSTURAL CHANGES IN THE PERFUSION AND FILLING OF THE PULMONARY VASCULAR BED. DALY WJ; GIAMMONA ST; ROSS JC; FEIGENBAUM H J Clin Invest; 1964 Jan; 43(1):68-76. PubMed ID: 14105233 [No Abstract] [Full Text] [Related]
32. [Effect of prostaglandin E1 on the systemic and regional hemodynamics of dogs]. Ismailov ShI; Flerov EV Kardiologiia; 1977 Jul; 17(7):122-6. PubMed ID: 926541 [TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E1 in infants with pulmonary atresia. Weir EK; Matisonn RE; Losman E; Chesler E S Afr Med J; 1978 Oct; 54(17):700-2. PubMed ID: 741285 [TBL] [Abstract][Full Text] [Related]
34. The significance of natriuretic peptide in treatment of pulmonary hypertension after mitral valve replacement. Chen T; Jiang N; Wang L; Guo Z; Han J; Jing S; Liu J J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1362-7. PubMed ID: 24252943 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary and systemic vascular responses of perinatal goats to prostaglandins E1 and E2. Cassin S; Tyler T; Leffler C; Wallis R Am J Physiol; 1979 Jun; 236(6):H828-32. PubMed ID: 443446 [TBL] [Abstract][Full Text] [Related]
36. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144 [TBL] [Abstract][Full Text] [Related]
37. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820 [TBL] [Abstract][Full Text] [Related]
38. [Effect of prostaglandin E1 on the left ventricle function in patients with congestive heart failure in the course of mitral valvular defects (author's transl)]. Dubiel JS; Pyzik Z; Szczeklik J; Mysik M; Horzela T Przegl Lek; 1978; 35(12):867-71. PubMed ID: 734153 [No Abstract] [Full Text] [Related]
39. Effect of E1 type prostaglandin on hypoxemia in a cyanotic congenital cardiac malformation. Moulaert A; Senders R; van Ertbruggen I; Huysmans H; Harinck E Eur J Cardiol; 1977 Jun; 5(4):321-5. PubMed ID: 891577 [TBL] [Abstract][Full Text] [Related]
40. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension]. Coulaud JM; Faitg R; Poler F; Rezgui N; Besse B; Lissac J Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():51-6. PubMed ID: 2147835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]